Brean Capital analyst Jason Wittes reiterated a Buy rating and $38 price target on Wright Medical (NASDAQ: WMGI), saying Augment ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Northland Capital Markets Remains Bullish on Wright Medical Group (WMGI) Following AUGMENT FDA Approval September 2, 2015 9:40 AM Wright Medical (WMGI) Augment Approval Removes Overhang, Leerink Partners SaysSeptember 2, 2015 6:24 AM Wright Medical Group's (WMGI) AUGMENT Bone Graf PMA Receives FDA ApproalSeptember 1, 2015 4:14 PM Wright Medical Group (WMGI) Reports FDA Approval of AUGMENT Bone GraftSeptember 1, 2015 4:13 PM